Market Cap 8.18M
Revenue (ttm) 33.56M
Net Income (ttm) -10.09M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -30.07%
Debt to Equity Ratio 5.70
Volume 21,400
Avg Vol 26,740
Day's Range N/A - N/A
Shares Out 4.17M
Stochastic %K 12%
Beta 0.69
Analysts Strong Sell
Price Target $9.00

Company Profile

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, and other...

Industry: Medical Devices
Sector: Healthcare
Phone: 215 619 3200
Fax: 215 619 3209
Address:
5 Walnut Grove Drive, Suite 140, Horsham, United States
Gunnar1
Gunnar1 Jul. 27 at 7:22 PM
$SSKN (2/2) What I don't like: - Technically, the chart is bad: the current price is below all moving averages, which is bearish. RSI 14 and KDJ are oversold. There is no clear reversal yet. I've no idea where the bottom is, so I'm just watching for now. Attached the weekly chart. I'm keeping an eye on the whole thing and might take a small starter position soon. We'll see... Maybe someone who knows this stock can share his or her thoughts?
0 · Reply
Gunnar1
Gunnar1 Jul. 27 at 7:19 PM
$SSKN (1/2) This came to may attention after some DD. What do I like? - PR in May 2025: CPT codes 96920–96922 have been revised by the AMA. This change means significant growth potential for SSKN through higher reimbursement rates, more treatments, and broader market presence. - Insiders hold approx. 39% of the shares. Uri Geiger, director and more than 10% owner of SSKN, purchased 230k common shares directly at a price of $3.14 per share exactly one year ago. Following the purchase, he is indirectly attributed 1,441,835 shares. - Tutes hold approx. 30%. Cash/share is $1.88, which is almost equal to the current share price. Cash balance as of March 31, 2025: 7.8 M, cash burn was reduced to USD 749k in Q1 (previous year: 1.55 M), which shows better capital discipline. - Analysts say strong buy, but that's only one analyst – and I don't pay much attention to that anyway. But still better than a sell recommendation, right? Short float: 0.14%, so shorts don't seem to bet against this stock. ...
0 · Reply
Bellbent
Bellbent Jul. 24 at 3:47 PM
$SSKN $PLRX $NAUT $QSI In biogem we trust!
0 · Reply
Bellbent
Bellbent Jul. 24 at 2:25 PM
$SSKN hurry and get under the desk! PT10
0 · Reply
Bellbent
Bellbent Jul. 24 at 2:16 PM
$QSI Still crossing my fingers on a 1.20 entry! Made great money flipping $NAUT and $PLRX as of late. Currently hifing in $SSKN all thanks to @BioGem
0 · Reply
Bellbent
Bellbent Jul. 24 at 2:14 PM
$SSKN might be a good time for the company to raise capital at $6 a share!
0 · Reply
tradeaksnn1
tradeaksnn1 Jul. 22 at 8:29 PM
$SSKN - Any news on this? Unusual jump in price after hours. Is it in anticipation of the upcoming earning mid-August? This would be too early for that IMO. If you have any news please share. GLTA.
1 · Reply
ValueVester
ValueVester Jul. 14 at 9:35 PM
$SSKN Some steady volume lately. Low volume, but steady. I have to imagine Uri and Accelmed will eventually sell Strata. In his better days he be looking for 200 mil. In today’s market, even if it was a 90 mil exit price it would equate to about $18/share. Wishful thinking? Maybe, but his track record is creating value, and selling. What is Strata worth? Not 2 bucks.
0 · Reply
GDS_investing
GDS_investing Jul. 11 at 4:35 PM
$INKT great call here glat my followers holding $VTVT $RFL $SSKN for next runup long
0 · Reply
Bellbent
Bellbent Jul. 8 at 3:43 PM
0 · Reply
Latest News on SSKN
STRATA Skin Sciences, Inc. (SSKN) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 10:51 PM EDT - 4 months ago

STRATA Skin Sciences, Inc. (SSKN) Q4 2024 Earnings Call Transcript


STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split

Apr 26, 2024, 5:20 PM EDT - 1 year ago

STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split


STRATA Skin Sciences Reports Third Quarter 2023 Revenue

Nov 14, 2023, 4:00 PM EST - 1 year ago

STRATA Skin Sciences Reports Third Quarter 2023 Revenue


STRATA Skin Sciences Reports Second Quarter 2023 Revenue

Aug 9, 2023, 4:01 PM EDT - 2 years ago

STRATA Skin Sciences Reports Second Quarter 2023 Revenue


Gunnar1
Gunnar1 Jul. 27 at 7:22 PM
$SSKN (2/2) What I don't like: - Technically, the chart is bad: the current price is below all moving averages, which is bearish. RSI 14 and KDJ are oversold. There is no clear reversal yet. I've no idea where the bottom is, so I'm just watching for now. Attached the weekly chart. I'm keeping an eye on the whole thing and might take a small starter position soon. We'll see... Maybe someone who knows this stock can share his or her thoughts?
0 · Reply
Gunnar1
Gunnar1 Jul. 27 at 7:19 PM
$SSKN (1/2) This came to may attention after some DD. What do I like? - PR in May 2025: CPT codes 96920–96922 have been revised by the AMA. This change means significant growth potential for SSKN through higher reimbursement rates, more treatments, and broader market presence. - Insiders hold approx. 39% of the shares. Uri Geiger, director and more than 10% owner of SSKN, purchased 230k common shares directly at a price of $3.14 per share exactly one year ago. Following the purchase, he is indirectly attributed 1,441,835 shares. - Tutes hold approx. 30%. Cash/share is $1.88, which is almost equal to the current share price. Cash balance as of March 31, 2025: 7.8 M, cash burn was reduced to USD 749k in Q1 (previous year: 1.55 M), which shows better capital discipline. - Analysts say strong buy, but that's only one analyst – and I don't pay much attention to that anyway. But still better than a sell recommendation, right? Short float: 0.14%, so shorts don't seem to bet against this stock. ...
0 · Reply
Bellbent
Bellbent Jul. 24 at 3:47 PM
$SSKN $PLRX $NAUT $QSI In biogem we trust!
0 · Reply
Bellbent
Bellbent Jul. 24 at 2:25 PM
$SSKN hurry and get under the desk! PT10
0 · Reply
Bellbent
Bellbent Jul. 24 at 2:16 PM
$QSI Still crossing my fingers on a 1.20 entry! Made great money flipping $NAUT and $PLRX as of late. Currently hifing in $SSKN all thanks to @BioGem
0 · Reply
Bellbent
Bellbent Jul. 24 at 2:14 PM
$SSKN might be a good time for the company to raise capital at $6 a share!
0 · Reply
tradeaksnn1
tradeaksnn1 Jul. 22 at 8:29 PM
$SSKN - Any news on this? Unusual jump in price after hours. Is it in anticipation of the upcoming earning mid-August? This would be too early for that IMO. If you have any news please share. GLTA.
1 · Reply
ValueVester
ValueVester Jul. 14 at 9:35 PM
$SSKN Some steady volume lately. Low volume, but steady. I have to imagine Uri and Accelmed will eventually sell Strata. In his better days he be looking for 200 mil. In today’s market, even if it was a 90 mil exit price it would equate to about $18/share. Wishful thinking? Maybe, but his track record is creating value, and selling. What is Strata worth? Not 2 bucks.
0 · Reply
GDS_investing
GDS_investing Jul. 11 at 4:35 PM
$INKT great call here glat my followers holding $VTVT $RFL $SSKN for next runup long
0 · Reply
Bellbent
Bellbent Jul. 8 at 3:43 PM
0 · Reply
Bellbent
Bellbent Jul. 3 at 4:06 PM
$SSKN should see a build up on stock price to 3+ before earnings IMO
0 · Reply
Bellbent
Bellbent Jul. 2 at 1:57 PM
$SSKN banking on a big revenue beat, last quarter was up 10% without this news! https://thedermdigest.com/medicare-win-strata-skin-sciences-gains-cpt-code-expansion-for-excimer-laser-use-in-skin-inflammatory-diseases/
0 · Reply
Bellbent
Bellbent Jun. 27 at 6:19 PM
$SSKN bought some today, gotta love it! @BioGem
0 · Reply
GDS_investing
GDS_investing Jun. 20 at 2:06 PM
$INVZ wow great call her (may 12 ) glta my followers now watch and add $VTVT $SSKN for next runup still hold $RFL
0 · Reply
RocketThief
RocketThief Jun. 17 at 3:00 PM
$SSKN doing some very slow accumulation here
0 · Reply
GDS_investing
GDS_investing Jun. 10 at 3:26 PM
$RFL great call here, glta my followers long and strong for p3 data NEWS still holding for long $AGEN $VTVT $SSKN
0 · Reply
GDS_investing
GDS_investing Jun. 9 at 5:10 PM
$RFL great call here, glta my followers long and strong for p3 data NEWS still holding for long $AGEN $VTVT $SSKN
0 · Reply
GDS_investing
GDS_investing Jun. 6 at 2:32 PM
market exploding time for low float runup i bet $SSKN float only 1.4m long watch $TQQQ $TNA $AGEN
0 · Reply
Dennist125
Dennist125 May. 28 at 2:21 AM
0 · Reply
Dennist125
Dennist125 May. 20 at 2:00 AM
$SSKN crazy
0 · Reply
ValueVester
ValueVester May. 19 at 5:52 PM
$SSKN Good news and good management. Today’s markets are just not recognizing value anymore.
0 · Reply
GDS_investing
GDS_investing May. 19 at 1:33 PM
$SSKN AWESOME " This change is expected to expand direct and clear reimbursement path and domestic market access from the roughly 10 million psoriasis patients covered today, to over 30 million potential patients, without the need to individually seek pre-determination of coverage, including" looonggg
0 · Reply